Methylthioninium chloride (methylene blue): update on central nervous system (CNS) toxicity (2014)

Government Record · Medicines and Healthcare products Regulatory Agency (MHRA), Drug Safety Update · December 11, 2014

Medicines et al., 2014-12-11: The UK regulator's advice is that IV methylthioninium chloride should be avoided in patients recently treated with SSRIs, clomipramine or venlafaxine, and reports 33 UK cases of CNS toxicity.

intravenous methylthioninium chloride should be avoided in patients who have been treated recently with serotonergic antidepressants, including SSRIs, clomipramine, and venlafaxine

Medicines et al., 2014-12-11: The UK regulator's advice is that IV methylthioninium chloride should be avoided in patients recently treated with SSRIs, clomipramine or venlafaxine, and reports 33 UK cases of CNS toxicity. Published 11 December 2014, MHRA Drug Safety Update. Same page states the total case count rose to 33 and that four reporters labelled the reaction serotonin syndrome. Also filed as MTO-19, MTP-39 (claims C2, C7, F3). Study type: regulatory record.